Literature DB >> 25790139

Laboratory-confirmed HIV and sexually transmitted infection seropositivity and risk behavior among sexually active transgender patients at an adolescent and young adult urban community health center.

Sari L Reisner1, Ralph Vetters, Jaclyn M White, Elijah L Cohen, M LeClerc, Shayne Zaslow, Sarah Wolfrum, Matthew J Mimiaga.   

Abstract

The sexual health of transgender adolescents and young adults who present for health care in urban community health centers is understudied. A retrospective review of electronic health record (EHR) data was conducted from 180 transgender patients aged 12-29 years seen for one or more health-care visits between 2001 and 2010 at an urban community health center serving youth in Boston, MA. Analyses were restricted to 145 sexually active transgender youth (87.3% of the sample). Laboratory-confirmed HIV and sexually transmitted infections (STIs) seroprevalence, demographics, sexual risk behavior, and structural and psychosocial risk indicators were extracted from the EHR. Analyses were descriptively focused for HIV and STIs. Stratified multivariable logistic regression models were fit for male-to-female (MTF) and female-to-male (FTM) patients separately to examine factors associated with any unprotected anal and/or vaginal sex (UAVS). The mean age was 20.0 (SD=2.9); 21.7% people of color, 46.9% white (non-Hispanic), 21.4% race/ethnicity unknown; 43.4% MTF, and 56.6% FTM; and 68.3% were on cross-sex hormones. Prevalence of STIs: 4.8% HIV, 2.8% herpes simplex virus, 2.8% syphilis, 2.1% chlamydia, 2.1% gonorrhea, 2.8% hepatitis C, 1.4% human papilloma virus. Only gonorrhea prevalence significantly differed by gender identity (MTF 2.1% vs. 0.0% FTM; p=0.046). Nearly half (47.6%) of the sample engaged in UAVS (52.4% MTF, 43.9% FTM, p=0.311). FTM more frequently had a primary sex partner compared to MTF (48.8% vs. 25.4%; p=0.004); MTF more frequently had a casual sex partner than FTM (69.8% vs. 42.7% p=0.001). In multivariable models, MTF youth who were younger in age, white non-Hispanic, and reported a primary sex partner had increased odds of UAVS; whereas, FTM youth reporting a casual sex partner and current alcohol use had increased odds of UAVS (all p<0.05). Factors associated with sexual risk differ for MTF and FTM youth. Partner type appears pivotal to understanding sexual risk in transgender adolescents and young adults. HIV and STI prevention efforts, including early intervention efforts, are needed in community-based settings serving transgender youth that attend to sex-specific (biological) and gender-related (social) pathways.

Entities:  

Keywords:  HIV; STI; transgender; youth

Mesh:

Year:  2015        PMID: 25790139      PMCID: PMC4624263          DOI: 10.1080/09540121.2015.1020750

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  29 in total

1.  Sexual risk behaviors and psychosocial health concerns of female-to-male transgender men screening for STDs at an urban community health center.

Authors:  Sari L Reisner; Jaclyn M White; Kenneth H Mayer; Matthew J Mimiaga
Journal:  AIDS Care       Date:  2013-11-09

Review 2.  Using health care records as sources of data for research.

Authors:  H vonKoss Krowchuk; M L Moore; L Richardson
Journal:  J Nurs Meas       Date:  1995

3.  A mixed methods study of the sexual health needs of New England transmen who have sex with nontransgender men.

Authors:  Sari L Reisner; Brandon Perkovich; Matthew J Mimiaga
Journal:  AIDS Patient Care STDS       Date:  2010-08       Impact factor: 5.078

4.  The interaction of drug use, sex work, and HIV among transgender women.

Authors:  Beth R Hoffman
Journal:  Subst Use Misuse       Date:  2014-06       Impact factor: 2.164

Review 5.  Sex work and HIV status among transgender women: systematic review and meta-analysis.

Authors:  Don Operario; Toho Soma; Kristen Underhill
Journal:  J Acquir Immune Defic Syndr       Date:  2008-05-01       Impact factor: 3.731

6.  'It's really a hard life': love, gender and HIV risk among male-to-female transgender persons.

Authors:  Rita M Melendez; Rogério Pinto
Journal:  Cult Health Sex       Date:  2007 May-Jun

7.  Unprotected sexual behavior and HIV risk in the context of primary partnerships for transgender women.

Authors:  Don Operario; Tooru Nemoto; Mariko Iwamoto; Toni Moore
Journal:  AIDS Behav       Date:  2011-04

8.  Gender Affirmation: A Framework for Conceptualizing Risk Behavior among Transgender Women of Color.

Authors:  Jae M Sevelius
Journal:  Sex Roles       Date:  2013-06-01

9.  Transgender female youth and sex work: HIV risk and a comparison of life factors related to engagement in sex work.

Authors:  Erin C Wilson; Robert Garofalo; Robert D Harris; Amy Herrick; Miguel Martinez; Jaime Martinez; Marvin Belzer
Journal:  AIDS Behav       Date:  2009-02-06

10.  Electronic medical records and the transgender patient: recommendations from the World Professional Association for Transgender Health EMR Working Group.

Authors:  Madeline B Deutsch; Jamison Green; JoAnne Keatley; Gal Mayer; Jennifer Hastings; Alexandra M Hall
Journal:  J Am Med Inform Assoc       Date:  2013-04-30       Impact factor: 4.497

View more
  35 in total

1.  Project Moxie: Results of a Feasibility Study of a Telehealth Intervention to Increase HIV Testing Among Binary and Nonbinary Transgender Youth.

Authors:  Rob Stephenson; Kieran Todd; Erin Kahle; Stephen P Sullivan; Michael Miller-Perusse; Akshay Sharma; Keith J Horvath
Journal:  AIDS Behav       Date:  2020-05

2.  Assessing Sexually Transmitted Infections and HIV Risk Among Transgender Women in Lima, Peru: Beyond Behavior.

Authors:  Kathleen E Moriarty; Eddy R Segura; Williams Gonzales; Jordan E Lake; Robinson Cabello; Jesse L Clark
Journal:  LGBT Health       Date:  2019-10       Impact factor: 4.151

3.  Partner-Level Factors Associated with Insertive and Receptive Condomless Anal Intercourse Among Transgender Women in Lima, Peru.

Authors:  Milan F Satcher; Eddy R Segura; Alfonso Silva-Santisteban; Jorge Sanchez; Javier R Lama; Jesse L Clark
Journal:  AIDS Behav       Date:  2017-08

4.  A systematic review of social stress and mental health among transgender and gender non-conforming people in the United States.

Authors:  Sarah E Valentine; Jillian C Shipherd
Journal:  Clin Psychol Rev       Date:  2018-03-28

5.  Perceived Barriers to HIV Prevention Services for Transgender Youth.

Authors:  Celia B Fisher; Adam L Fried; Margaret Desmond; Kathryn Macapagal; Brian Mustanski
Journal:  LGBT Health       Date:  2018-08-02       Impact factor: 4.151

6.  Longitudinal Analysis of Syndemic Psychosocial Problems Predicting HIV Risk Behavior Among a Multicity Prospective Cohort of Sexually Active Young Transgender Women in the United States.

Authors:  Matthew J Mimiaga; Jaclyn M W Hughto; Katie B Biello; Christopher M Santostefano; Lisa M Kuhns; Sari L Reisner; Robert Garofalo
Journal:  J Acquir Immune Defic Syndr       Date:  2019-06-01       Impact factor: 3.731

7.  LifeSkills for Men (LS4M): Pilot Evaluation of a Gender-Affirmative HIV and STI Prevention Intervention for Young Adult Transgender Men Who Have Sex with Men.

Authors:  Sari L Reisner; Jaclyn M White Hughto; Dana J Pardee; Lisa Kuhns; Rob Garofalo; Matthew J Mimiaga
Journal:  J Urban Health       Date:  2016-02       Impact factor: 3.671

8.  Characterizing the HIV Prevention and Care Continua in a Sample of Transgender Youth in the U.S.

Authors:  Sari L Reisner; Laura Jadwin-Cakmak; Jaclyn M White Hughto; Miguel Martinez; Liz Salomon; Gary W Harper
Journal:  AIDS Behav       Date:  2017-12

9.  Current research gaps: a global systematic review of HIV and sexually transmissible infections among transgender populations.

Authors:  Sarah MacCarthy; Tonia Poteat; Zhiyu Xia; Nicolette L Roque; Ashley Hyun Jin Kim; Stefan Baral; Sari L Reisner
Journal:  Sex Health       Date:  2017-10       Impact factor: 2.706

10.  Epidemiology of HIV, Sexually Transmitted Infections, Viral Hepatitis, and Tuberculosis Among Incarcerated Transgender People: A Case of Limited Data.

Authors:  Tonia C Poteat; Mannat Malik; Chris Beyrer
Journal:  Epidemiol Rev       Date:  2018-06-01       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.